The clinical application of ctDNA to predict response to neoadjuvant chemoradiotherapy in patients with locally-advanced rectal cancer
Abstract Colorectal cancer is a major cause of cancer-related deaths worldwide. A third of colorectal cancers reside in the rectum. Many patients with rectal cancer present in the locally-advanced stage which needs multi-modality therapy usually starting with neoadjuvant chemo-radiotherapy followed...
Saved in:
Main Authors: | Parmida Sadat Pezeshki (Author), Reza Ghalehtaki (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2023-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evaluation of ctDNA in the Prediction of Response to Neoadjuvant Therapy and Prognosis in Locally Advanced Rectal Cancer Patients: A Prospective Study
by: Marina Morais, et al.
Published: (2023) -
Predicting Neoadjuvant Chemoradiotherapy Response in Locally Advanced Rectal Cancer Using Tumor-Infiltrating Lymphocytes Density
by: Xu Y, et al.
Published: (2021) -
The Outcome of Induction Chemotherapy, Followed by Neoadjuvant Chemoradiotherapy and Surgery, in Locally Advanced Rectal Cancer
by: Ali Yaghobi Joybari, et al.
Published: (2021) -
Prediction of the treatment response in ovarian cancer: a ctDNA approach
by: Mina Sharbatoghli, et al.
Published: (2020) -
Characterization of the tumor microenvironment and identification of spatially predictive biomarkers associated with beneficial neoadjuvant chemoradiotherapy in locally advanced rectal cancer
by: Shifen Zhang, et al.
Published: (2023)